Show simple item record

2008-12-20Zeitschriftenartikel DOI: 10.1515/JPM.2009.053
Visfatin in human pregnancy
dc.contributor.authorMazaki-Tovi, Shali
dc.contributor.authorRomero, Roberto
dc.contributor.authorKusanovic, Juan Pedro
dc.contributor.authorVaisbuch, Edi
dc.contributor.authorErez, Offer
dc.contributor.authorThan, Nandor Gabor
dc.contributor.authorChaiworapongsa, Tinnakorn
dc.contributor.authorNhan-Chang, Chia-Ling
dc.contributor.authorPacora, Percy
dc.contributor.authorGotsch, Francesca
dc.contributor.authorYeo, Lami
dc.contributor.authorKim, Sun Kwon
dc.date.accessioned2017-06-17T01:06:50Z
dc.date.available2017-06-17T01:06:50Z
dc.date.created2009-06-26
dc.date.issued2008-12-20
dc.identifier.issn1619-3997
dc.identifier.urihttp://edoc.hu-berlin.de/18452/10098
dc.description.abstractObjective: Adipose tissue dysfunction, characterized by dysregulation of adipokines production and/or secretion, has been implicated in the pathophysiology of type-2 diabetes mellitus, a metabolic complication closely related to gestational diabetes mellitus (GDM). Recently, an association between circulating maternal visfatin, a novel adipokine with metabolic and immunoregulatory properties, and impaired glucose metabolism as well as with altered fetal growth, has been proposed. The aims of this study were to determine whether there is an association between maternal plasma visfatin concentration, GDM, and a large-for-gestational-age (LGA) newborn. // Study design: This cross-sectional study, included pregnant women at term in the following groups: 1) normal pregnancy and an appropriate-for-gestational-age (AGA) neonate (n=54); 2) normal pregnancy and an LGA newborn (n=47); 3) GDM and an AGA newborn (n=56); 4) GDM and an LGA newborn (n=45). The study population was further stratified by first trimester BMI (eng
dc.language.isoeng
dc.publisherKooperation de Gruyter
dc.subjectadipokineeng
dc.subjectadipose tissueeng
dc.subjectappropriate-for-gestational-age (AGA)eng
dc.subjectgestational diabetes mellitus (GDM)eng
dc.subjectlarge-for-gestational-age (LGA)eng
dc.subjectpre-B cell colony-enhancing factor (PBEF)eng
dc.subjectvisfatineng
dc.subject.ddc610 Medizin
dc.titleVisfatin in human pregnancy
dc.typearticle
dc.subtitlematernal gestational diabetes vis-à-vis neonatal birthweight
dc.identifier.urnurn:nbn:de:kobv:11-10098733
dc.identifier.doi10.1515/JPM.2009.053
dc.identifier.doihttp://dx.doi.org/10.18452/9446
local.edoc.container-titleJournal of perinatal medicine
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-volume37
local.edoc.container-issue3
local.edoc.container-year2009
local.edoc.container-firstpage218
local.edoc.container-lastpage231
dc.description.versionPeer Reviewed

Show simple item record